APA (7th ed.) Citation

Bauer, A., Sappler, N., von Stülpnagel, L., Klemm, M., Schreinlechner, M., Wenner, F., . . . Massberg, S. (2022). Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): A prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. The lancet. Digital health, 4(2), . https://doi.org/10.1016/S2589-7500(21)00253-3

Chicago Style (17th ed.) Citation

Bauer, Axel, et al. "Telemedical Cardiac Risk Assessment by Implantable Cardiac Monitors in Patients After Myocardial Infarction with Autonomic Dysfunction (SMART-MI-DZHK9): A Prospective Investigator-initiated, Randomised, Multicentre, Open-label, Diagnostic Trial." The Lancet. Digital Health 4, no. 2 (2022). https://doi.org/10.1016/S2589-7500(21)00253-3.

MLA (9th ed.) Citation

Bauer, Axel, et al. "Telemedical Cardiac Risk Assessment by Implantable Cardiac Monitors in Patients After Myocardial Infarction with Autonomic Dysfunction (SMART-MI-DZHK9): A Prospective Investigator-initiated, Randomised, Multicentre, Open-label, Diagnostic Trial." The Lancet. Digital Health, vol. 4, no. 2, 2022, https://doi.org/10.1016/S2589-7500(21)00253-3.